Home » Topics » BioWorld Science, Nephrology

BioWorld Science, Nephrology
RSS

Increased tissue levels of resiniferatoxin in pig bladder wall after electrical stimulation

Oct. 10, 2003

Approvable letter issued for Enablex for overactive bladder

Oct. 8, 2003

S.O.A.R. collaboration to evaluate KRX-101 for focal segmental glomerulosclerosis

Oct. 8, 2003

Improved erectile dysfunction reported with moxonidine in hypertensive men

Oct. 8, 2003

VR1 antagonists for urinary incontinence and pain claimed by Abbott

Oct. 2, 2003

Yamanouchi claims new BK(Ca) channel openers for use in urinary incontinence

Oct. 1, 2003

Watson and UCB enter marketing and supply agreement on Oxytrol

Sep. 26, 2003

Indole-based alpha1A-adrenoceptor agonists for urinary incontinence and other uses

Sep. 26, 2003

Novel agents for urinary incontinence described by Mochida and Asahi Glass

Sep. 25, 2003

New agents with utility in urinary incontinence patented by Boehringer Ingelheim

Sep. 18, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 15, 2026.
ASGCT 2026: Circular RNA, the new beast in gene and cell therapy
BioWorld
Circular RNA (circRNA) is not a new concept, but it is a novel strategy in the field of gene and cell therapy. While mRNA vaccines have revolutionized medicine,...
ASGCT 2026: Uncovering the mechanisms of AAV toxicity
BioWorld
Gene therapies rely on vectors to reach the target tissue where they act, such as adeno-associated viruses (AAVs) or lipid nanoparticles (LNPs), among other...
Fosun secures rights to Aribio’s AR-1001 in potential $4.7B deal
BioWorld
Shanghai Fosun Pharmaceutical (Group) Co. Ltd. is paying $60 million up front for an option to secure exclusive rights to Aribio Co. Ltd.’s oral phase III-stage...
Biogen AD drug shows tau, cognition benefit, despite trial miss
BioWorld
Biogen Inc. has decided to advance diranersen (BIIB-080) into registrational trials for early Alzheimer’s disease, even though the antisense oligonucleotide...